Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1583 Health Care Dr
Rock Hill, SC 29732Phone+1 803-329-7772Fax+1 803-329-9821
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1999 - 2002
Jamaica Hospital Medical CenterResidency, Internal Medicine, 1996 - 1999
N.H.L Municipal Medical CollegeClass of 1984
Certifications & Licensure
NC State Medical License 2003 - 2025
SC State Medical License 2002 - 2025
NY State Medical License 1999 - 2018
FL State Medical License 2002 - 2006
PA State Medical License 1999 - 2006
NJ State Medical License 2000 - 2005
MI State Medical License 1999 - 2000- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 10 citationsReal-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer.Whitney C Rhodes, Richard W DeClue, Neil A. Accortt, Ran Jin, Darcie Sandschafer
Future Oncology. 2021-10-26 - 55 citationsThe cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems.Tore K Kvien, Kashyap Patel, Vibeke Strand
Seminars in Arthritis and Rheumatism. 2022-02-01 - 85 citationsChemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study.Kashyap Patel, Kevin L. Sullivan, David Berd, Michael J. Mastrangelo, Carol L. Shields
Melanoma Research. 2005-08-01
Press Mentions
Oxford Biodynamics to Present on Its Line of EpiSwitch® Products for Companion Diagnostics in Cancer Immunotherapy at the 14th World Summit for Clinical Biomarkers and Companion Diagnostics in Boston, MAJuly 25th, 2024- Covid Might Be to Blame for an Uptick in Rare CancersJune 20th, 2024
- Rare and ‘Unusual’ Cancers Are Emerging After the Covid Pandemic – and Doctors Fear an Unlikely Culprit Is to BlameJune 7th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
